141 related articles for article (PubMed ID: 35076441)
1. Modernizing regulations for treating opioid use disorder during the COVID-19 pandemic.
Iacono TM
JAAPA; 2022 Feb; 35(2):57-59. PubMed ID: 35076441
[TBL] [Abstract][Full Text] [Related]
2. Upsurges in the joblessness and opioid epidemics in the United States after the COVID-19 epidemic: the plight of the jobless patient in the clinic.
Volinn E; Loeser JD
Pain; 2021 Jun; 162(6):1608-1611. PubMed ID: 33657577
[No Abstract] [Full Text] [Related]
3. The Opioid Epidemic During the COVID-19 Pandemic.
Haley DF; Saitz R
JAMA; 2020 Oct; 324(16):1615-1617. PubMed ID: 32945831
[No Abstract] [Full Text] [Related]
4. When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis.
Becker WC; Fiellin DA
Ann Intern Med; 2020 Jul; 173(1):59-60. PubMed ID: 32240291
[TBL] [Abstract][Full Text] [Related]
5. Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.
Currie JM; Schnell MK; Schwandt H; Zhang J
JAMA Netw Open; 2021 Apr; 4(4):e216147. PubMed ID: 33856474
[TBL] [Abstract][Full Text] [Related]
6. A health crisis within a health crisis: Opioid access in the COVID-19 pandemic.
Narayan A; Balkrishnan R
Subst Abus; 2021; 42(2):148-152. PubMed ID: 33849399
[TBL] [Abstract][Full Text] [Related]
7. Employing telehealth strategies for opioid addiction during COVID-19: implications for social work health care.
Kim SH; Tesmer O
Soc Work Health Care; 2021 Aug; 60(6-7):499-508. PubMed ID: 34278979
[TBL] [Abstract][Full Text] [Related]
8. Opioid use disorder and COVID-19: Implications for policy and practice.
Mitchell M; Shee K; Champlin K; Essary AC; Evans M
JAAPA; 2021 Jun; 34(6):1-4. PubMed ID: 34031321
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine Opioid Treatment During the COVID-19 Pandemic.
Luigi M; Luo M; Maes EJP
JAMA Intern Med; 2021 Aug; 181(8):1135. PubMed ID: 33843962
[No Abstract] [Full Text] [Related]
10. Buprenorphine Opioid Treatment During the COVID-19 Pandemic-Reply.
Nguyen TD; Saloner B; Stein BD
JAMA Intern Med; 2021 Aug; 181(8):1135-1136. PubMed ID: 33843947
[No Abstract] [Full Text] [Related]
11. TIME TO REVISIT UNEVEN POLICY IN THE UNITED STATES FOR MEDICATION FOR OPIOID USE DISORDER DURING COVID-19.
Pena E; Ahmed S
Addiction; 2020 Oct; 115(10):1978-1979. PubMed ID: 32447795
[No Abstract] [Full Text] [Related]
12. COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership.
Levander XA; Pytell JD; Stoller KB; Korthuis PT; Chander G
Subst Abus; 2022; 43(1):633-639. PubMed ID: 34666636
[No Abstract] [Full Text] [Related]
13. Trends in pharmacy-based dispensing of buprenorphine, extended-release naltrexone, and naloxone during the COVID-19 pandemic by age and sex - United States, March 2019 - December 2020.
Cremer LJ; Board A; Guy GP; Schieber L; Asher A; Parker EM
Drug Alcohol Depend; 2022 Mar; 232():109192. PubMed ID: 35065513
[TBL] [Abstract][Full Text] [Related]
14. The impact of COVID-19 on opioid treatment programs in the United States.
Goldsamt LA; Rosenblum A; Appel P; Paris P; Nazia N
Drug Alcohol Depend; 2021 Nov; 228():109049. PubMed ID: 34600258
[TBL] [Abstract][Full Text] [Related]
15. Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study.
Oviedo-Joekes E; MacDonald S; Boissonneault C; Harper K
Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):22. PubMed ID: 33673847
[TBL] [Abstract][Full Text] [Related]
16. Integrating Telemedicine for Medication Treatment for Opioid Use Disorder in Rural Primary Care: Beyond the COVID Pandemic.
Hser YI; Mooney LJ
J Rural Health; 2021 Jan; 37(1):246-248. PubMed ID: 32579751
[No Abstract] [Full Text] [Related]
17. Pain Management Revisited.
Carr E
Clin J Oncol Nurs; 2021 Aug; 25(4):361-362. PubMed ID: 34269344
[TBL] [Abstract][Full Text] [Related]
18. Changes in the availability of medications for opioid use disorder in prisons and jails in the United States during the COVID-19 pandemic.
Dadiomov D; Trotzky-Sirr R; Shooshtari A; Qato DM
Drug Alcohol Depend; 2022 Mar; 232():109291. PubMed ID: 35033953
[TBL] [Abstract][Full Text] [Related]
19. Adolescents and opioid-related outcomes amidst the COVID-19 pandemic.
Romero RA; Young SD
J Addict Dis; 2022; 40(1):126-130. PubMed ID: 33955321
[TBL] [Abstract][Full Text] [Related]
20. "How will I get my next week's script?" Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic.
Krawczyk N; Bunting AM; Frank D; Arshonsky J; Gu Y; Friedman SR; Bragg MA
Int J Drug Policy; 2021 Jun; 92():103140. PubMed ID: 33558165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
